U.S. market Closed. Opens in 11 hours 35 minutes

NVCT | Nuvectis Pharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
RevenueN/A149.00KN/AN/A
Cost of Revenue22.90M19.23M12.89MN/A
Gross Profit-22.90M-19.09M-12.89MN/A
Operating Expenses22.90M19.23M12.89M10.00K
Selling, General & Admin7.52M6.01M3.35M10.00K
Research & Development15.38M13.23M9.54MN/A
Other Operating ExpensesN/AN/AN/AN/A
Operating Income-22.90M-19.23M-12.89M-10.00K
Other Expenses / Income637.00K149.00K4.00KN/A
Before Tax Income-22.26M-19.09M-12.89M-10.00K
Income Tax Expenses1.00K-298.00K-4.00K-24.00
Net Income-22.26M-18.79M-12.89M-10.00K
Interest ExpensesN/A149.00KN/AN/A
Basic Shares Outstanding15.56M12.66M12.72M12.72M
Diluted Shares Outstanding15.56M12.66M12.72M12.72M
EBITDA-22.90M-19.23M-12.89M-10.00K
EBITDA Margin0.00%-12,908.72%0.00%0.00%
EBIT-22.26M-18.94M-12.89M-10.02K
EBIT Margin0.00%-12,708.72%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙